A big fat magic marker

Confusion reigns because of the sheer amount of information flying around us. Yet all that activity should bring us comfort as it's helping fight the pandemic and its economic effects, argues head of fixed income Bryn Jones.

Pulp fiction

Do you remember that scene in Pulp Fiction where Uma Thurman is brought back from the brink with an adrenaline shot? Once, my son had a similar – more G-rated! – type of medical miracle.

When he was younger, asthma and croup used to give him the worst coughs. I’ll never forget one night when we had to call the ambulance and he was given a shot of dexamethasone. This anti-inflammatory drug stopped his coughing instantly. Apart from Pulp Fiction, I have never seen anything like it.

This is the drug being trialled at Oxford University which has been shown to dramatically improve survival rates for those admitted to hospital. I certainly reckon they might be onto something here: it’s one powerful drug. It could help the world’s health systems deal with a second wave of the virus without crippling society once again. Another exciting breakthrough has come from my old uni: the Institute of Immunology and Immunotherapy at Birmingham has developed an antibody test that it claims is simpler and more accurate than current tests because it searches for a different viral marker in the blood. Such a test would make determining who has already had the virus (and therefore likely has immunity) much quicker and help the world get back to some semblance of normality.

Promising developments like these help drive optimism and push stock and bond markets higher. Yet there is never a silver bullet for fixing something as complex as what we’re living through. China has had an iron-clad testing, tracing and quarantining regime for virtually all of 2020, yet even it is experiencing new outbreaks. The world is in such a tangle of different stages of the pandemic. China is closing schools and shutting down parts of Beijing two months after ending its lockdown of epicentre Wuhan. Roughly 15,000-30,000 new cases are reported each day in the US even as it comes out of lockdown. Parisian cafes and restaurants have already reopened with limited social distancing even as just a few hundred miles north, across the Channel, we’re still a month at least from enjoying a bite out. Yet I hear my kids are going back to school on Monday. Meanwhile, the developing world is still in the midst of strict lockdowns as the virus spreads rapidly. Globally, the pandemic is still growing; this week we posted a grim new record of 142,000 new cases in a single day.

This confusing global picture, allied with simultaneously released really good and really terrible economic numbers, will continue to sow confusion among people and markets. The battle between optimism and pessimism is creating see-saw movements in both shares and bonds that aren’t going anywhere soon. Faced with this picture, central banks are taking no chances. They have already fired off a stupendous amount of support for markets and businesses, from cutting interest rates to nigh on zero and extending sweetheart loans to companies, to buying billions of pounds’ worth of bonds to keep borrowing rates low for governments and businesses.

Just this week the Bank of England added another £100 billion to its quantitative easing (QE) programme. Yet at the same time the bank cut the amount of bonds it buys each week under QE from £13.5 billion to £4.5 billion. To put these massive figures into context, buying £13.5 billion each week for a year would equate to about 25% of the country’s GDP, while £4.5 billion weekly would amount to just 8%. This week the US Federal Reserve is finally buying corporate bonds directly after a spell of purchasing them through ETFs. Brazil’s central bank has slashed its interest rate by another 0.75%, taking it to a record low of 2.25%, while Chile has announced $8billion of QE.

The sheer weight of information and narrative and stats thrown around at the moment can be overwhelming. Yet after I take a moment it actually gives me some comfort. There’s so much going on, so many unprecedented responses to the dangers we face, that it’s hard to stay on top of it all. It’s hard to keep track of all the ways we as a global society are trying to fight this virus together. This is good medicine that brings real comfort.

 

 

Important legal information

This area of the site is for professional advisers

Please read this page before proceeding, it explains certain legal and regulatory restrictions applicable to the distribution of this information. It is your responsibility to inform yourselves of and to observe all applicable laws and regulations of the relevant jurisdiction.

This section of the website is directed only at investment advisers and other financial intermediaries who are authorised and regulated by the Financial Conduct Authority (FCA).

The information provided in this site is directed at UK investment advisers only and must not be circulated to private clients or to the general public. It does not constitute an offer to sell, or solicit an offer to purchase any investments by anyone in any jurisdiction in which such offer or solicitation is not authorised or in which a member of the Rathbone Group is not authorised to do so.

I confirm that I am an investment intermediary authorised and regulated by the Financial Conduct Authority. I have read and understood the legal information and risk warnings below:

Important Information (Terms and Conditions)

The information contained on this site is believed to be accurate at the date of publication but no warranty of accuracy is given and the information is subject to change without notice. Any opinions or estimates included herein constitute a judgement as of the date of publication and are subject to change without notice. Furthermore, no responsibility is accepted for the accuracy of any information contained within sites provided by third parties that may have links to or from our pages.

Rathbone Investment Management Limited ("RIM") is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority. Registered Office: Port of Liverpool Building, Pier Head, Liverpool L3 1NW. Registered in England No 01448919.

In accordance with regulations, all electronic communications and telephone calls between Rathbones and its clients are recorded and stored for a minimum period of six months.

The information provided in this site is directed at UK investors only. It does not constitute an offer to sell, or solicit an offer to purchase any investments by anyone in any jurisdiction in which such offer or solicitation is not authorised or in which a member of the Rathbone Group is not authorised to do so.

In particular, the information herein is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities in France and the United States of America to or for the benefit of United States persons (being resident in the United States of America or partnerships or corporations organised under the laws of the United States of America or any state, territory or possession thereof).

In order to comply with money laundering and other regulations, additional documentation for identification purposes may be required.

Rathbones shall have no liability for any data transmission errors such as data loss, damage or alteration of any kind including, but not limited to, any direct, indirect or consequential damage arising out of the use of services provided or referred to in this website.

Past performance should not be seen as an indication of future performance.

The value of investments and the income from them can fall as well as rise and you may not get back the amount originally invested, particularly if your client does not continue with the investment over the longer term.

Changes in the rate of exchange between currencies may cause the value of an investment to go up or down.

Interest rate fluctuations are likely to affect the capital value of investments within bond funds. When long term interest rates rise the capital value of units is likely to fall and vice versa. The effect will be more apparent on funds that invest significantly in long dated securities. The value of capital and income will fluctuate as interest rates and credit ratings of the issuing companies change.

Tax levels and reliefs are those currently applicable and may change and the value of any tax advantage will depend on individual circumstances.

Investing in emerging markets or small companies may be potentially volatile, as these investments are high risk.

The design, text and images are owned, except as expressly stated by members of the Rathbone Group. They may not be copied, transmitted, displayed, performed, distributed, licensed, altered, framed, stored or otherwise used in whole or in part or in any manner without the written consent of Rathbones except to the extent permitted and under the procedures specified in the copyright Designs and Patents Act 1988, as amended and then only with notices of Rathbones' rights.

Rate this page:
Average: 5 (6 votes)

Subscribe to the In the KNOW blog email

Archive